Sunday, February 24, 2013

Mysterious brain clumps behind dementia identified


Caregivers and healthcare professionals, here is some great information

Here is a great dementia resource for caregivers and healthcare professionals,


Your residents will love the Amazon Kindle Fire


Here is information on being the best caregiver you can be


Here is a way for nurses administrators, social workers and other health care  professionals to get an easyceu or two


Follow alzheimersideas on twitter

The Dementia Caregiver's Little Book of Hope [Kindle Edition

FoxNews

By Tanya Lewis

Certain forms of dementia may be caused by a gene mutation that makes proteins in the brain clump together, a new study finds.
The most common cause of frontotemporal dementia and a motor neuron disease called amyotrophic lateral sclerosis (ALS, or Lou Gehrig's disease) is a genetic mutation that creates extra copies of a DNA sequence, but the actual mechanism of the diseases is unknown. A team of researchers has now found that proteins, molecules that normally help cells function, are being produced from the mutated gene and appear to be causing the clumping seen in both those diseases.
The findings, described online Feb. 7 in the journal Science, could explain how these diseases arise and might even be treated.
About 10 percent of FTLD (frontotemporal lobar degeneration) and ALS patients have a mutation in the C9orf72 gene, which contains a short repeated DNA sequence. Healthy people have about 25 repeats of this sequence, but there are hundreds of repeats in these patients. Their brains exhibit telltale clumps of proteins in the hippocampus and cerebellum regions.
While proteins in other forms of dementia are known, patients with this mutation have clumps of other, unknown proteins, said study co-author Dieter Edbauer, a neuroscientist at Ludwig Maximilian University of Munich, in Germany. The mutated gene lacks the label that normally tells cells to start making a protein, and is located in a stretch of the DNA that isn't normally active.
Protein mystery
Edbauer and his colleagues hypothesized that if the gene were somehow activated, it would cause three different proteins to be made, and these proteins would aggregate in cells and cause disease.
To test their hypothesis, the researchers took both diseased and healthy brain tissue from deceased patients and filtered it through a fine mesh. Clumps of brain tissue from the patients got stuck in the mesh. By making antibodies (proteins produced by the body to target and fight off foreign invaders) that recognized the three specific proteins, the scientists were able to determine that these were the proteins in the clumps.  
"This study helps to resolve a major question about how C9orf72 mutations cause FTD and ALS," said neurologist Adam Boxer of the University of California, San Francisco, who was not involved in the study.
"It suggests that these mutations can lead to creation of a new toxic protein that aggregates and accumulates in cells, similar to other neurodegenerative diseases such as Huntington's and Alzheimer's, which are also associated with toxic protein aggregates," Boxer told LiveScience. [10 Odd Facts About the Brain]
Others agree that the findings, if replicated, will be important. "It would be good to confirm their results using an independent method," said neuropathologist Ian Mackenzie of Vancouver General Hospital and the University of British Columbia, in Canada.
Understanding the diseases
There are several possible explanations for how the proteins are being made. One is that the ribosome, the cellular machinery that reads genetic instructions to make proteins, is misreading the mutated gene. Another possibility is that the repeated sequence is forming a hairpin shape that attracts the ribosome and tells it to make proteins.
It's unclear whether the clumps are causing the diseases or are simply markers. If the protein clumps are in fact responsible, scientists might be able to treat the disease by getting rid of those proteins, Edbauer said.
FTD and ALS are characterized by personality changes, language abnormalities and movement disorders, which often appear before the age of 65. There is currently no cure.


Friday, February 22, 2013

NEW STUDY SAYS SMOKING POT COULD HELP CURE DEMENTIA


Caregivers and healthcare professionals, here is some great information

Here is a great dementia resource for caregivers and healthcare professionals,


Your residents will love the Amazon Kindle Fire


Here is information on being the best caregiver you can be


Here is a way for nurses administrators, social workers and other health care  professionals to get an easyceu or two


Follow alzheimersideas on twitter

The Dementia Caregiver's Little Book of Hope [Kindle Edition


SYDNEY MORNING HERALD (Australia)
SYDNEY – Australian scientists have discovered that cannabis could help reverse dementia.
Researchers from Neuroscience Research Australia (NRA) believe one of the main active ingredients in cannabis – cannabidiol – could reverse some of the symptoms of memory loss, reports the Sydney Morning Herald.
Tim Karl, a senior NRA researcher says that cannabidiol has anti-inflammatory, antioxidant and other effects that could be beneficial for the brain.
According to Karl, “Back in the day cannabis was used for medical purposes, I'm talking 200 years, 100 years back, then at some point people discovered it had other effects and, as quite often happens in our society, people decided it was a bad drug.” 
He told the Sydney Morning Herald that even though “most of the components [of marijuana] are detrimental – they worsen your cognitive performance and have psychoactive effects – cannabidiol seems to not have any of these negative effects.”
The researchers injected cannabidiol into mice that had been bred with Alzheimer’s-like symptoms. They found that the mice showed drastic improvements during tests where they had to remember objects and other mice. The research will be presented at the annual meeting of the Australian Neuroscience Society this week.

Wednesday, February 20, 2013

Researchers hope to learn if aspirin can fight dementia


ThCaregivers and healthcare professionals, here is some great information

Here is a great dementia resource for caregivers and healthcare professionals,

Your residents will love the Amazon Kindle Fire

Here is information on being the best caregiver you can be

Here is a way for nurses administrators, social workers and other health care  professionals to get an easyceu or two

Follow alzheimersideas on twitter

The Dementia Caregiver's Little Book of Hope [Kindle Edition

e University of Texas Health Science Center is looking for more people to help them find answers to this question.
The Regional Academic Health Center in Harlingen is one of about 30 sites in the country where the study is being conducted, Dr. Sara Espinoza, the local principal investigator, said.
The study is called Aspirin in Reducing Events in the Elderly. The study’s principal investigator is Dr. Richard Grimm, medical director of the Berman Center for Outcomes and Clinical Research in Minneapolis.
“We know that aspirin prevents heart disease and stroke in middle-aged people,” said Espinoza, an associate professor of medicine at the UT Health Science Center in San Antonio. “There is some evidence that aspirin may prevent dementia or cognitive impairment.”
Past studies suggest that aspirin, as an anti-inflammatory drug, could be a protective for dementia, she said.
The study includes persons 65 and older who are in good health. Some will be given aspirin; others will take a placebo. They will then be monitored annually for five years. Harlingen residents participating in the study are tested and examined at the RAHC’s Clinical Research Unit.
Espinoza said the study has far-reaching effects because conditions such as dementia, including Alzheimer’s disease, could be caused by inflammation.
Diabetes is considered an inflammatory condition, and that can lead to disability. Therefore, the study is also being conducted to see if aspirin can reduce the possibility of people becoming disabled to the point where they are unable to care for themselves.
The study is also being conducted at sites in Australia, begun about two years ago. Espinoza said the study’s operators intend to enroll people in the program until December, but the deadline could be extended.
The South Texas site, which includes the RAHC as an extension of the University of Texas Health Science Center in San Antonio, has about 219 subjects enrolled, Espinoza said, with 25 to 30 enrolled in Harlingen.
Travis M. Whitehead writes for the Valley Morning Star in Harlingen. 
 ASPIRIN STUDY
>> Persons interested in participating in the study can call 1 (877) 524-3265 or visit www.ASPREE.org.

Monday, February 18, 2013

Dementia aggression difficult to control


Caregivers and healthcare professionals, here is some great information

Here is a great dementia resource for caregivers and healthcare professionals,


Your residents will love the Amazon Kindle Fire


Here is information on being the best caregiver you can be


Here is a way for nurses administrators, social workers and other health care  professionals to get an easyceu or two


Follow alzheimersideas on twitter

The Dementia Caregiver's Little Book of Hope [Kindle Edition

Carol Bursack

It’s likely that someday a physician will be able to order a blood test which will identify the exact medication needed to balance a person’s brain chemistry. Unfortunately, we are a long way from that ideal. Doctor and other professionals try their best to find a medication that will help, but finding the optimum medication is difficult.

Zyprexa (olanzapine) is an atypical antipsychotic medication. Exactly how it works isn’t known, though it’s thought to work by changing the actions of certain chemicals in the brain. The drug is generally used to treat the symptoms of psychotic conditions such as schizophrenia and bipolar disorder (manic depression), but doctors can use it for other illnesses if they think it may help the patient. Many doctors use atypical antipsychotic medications for dementia symptoms with varying results. Sleepiness is one of the most common side effects.

Problem behavior would be difficult for anyone to handle alone. You may need to consider in-home caregiving help or a good nursing home. You’d still be her caregiver, but you’d be part of a team. With people to help with medication management and aggression issues, you’d be able to focus more on your personal relationship with your love one. Remember that you need to consider your own health as well as your loved one's.

Saturday, February 16, 2013

Alzheimer's Disease and 8 Potential Natural Treatments


Caregivers and healthcare professionals, here is some great information

Here is a great dementia resource for caregivers and healthcare professionals,


Your residents will love the Amazon Kindle Fire


Here is information on being the best caregiver you can be


Here is a way for nurses administrators, social workers and other health care  professionals to get an easyceu or two


Follow alzheimersideas on twitter

The Dementia Caregiver's Little Book of Hope [Kindle Edition

EmaxHealth


Alzheimer’s disease is one of the most challenging and serious health problems facing the world’s population, and research into prevention and treatment remains a high priority. Among the studies are those exploring potential natural treatments for this devastating disease.

What’s new in natural treatments for Alzheimer’s?

Although scientists have not yet uncovered a cure or an effective way to prevent or treat Alzheimer’s disease, every research endeavor reveals something investigators can use to help them reach their goal. A case in point is new research from the University of Leeds (UL), in which scientists identified the process by which two chemicals found in two natural substances—red wine and green tea—may interfere with the progression of Alzheimer’s disease.
Even though the research is still in the laboratory stage, the study’s lead researcher, Professor Nigel Hooper of the Faculty of Biological Sciences of UL, noted that “this is an important step in increasing our understanding of the cause and progression of Alzheimer’s disease.”
\Basically, the research team discovered how extracts of resveratrol from red wine and epigallocatechin gallate (EGCG) from green tea can help prevent the death of brain cells. In Alzheimer’s disease, nerve cells in the brain die when amyloid proteins accumulate in the brain, clump together into balls, and attach themselves to nerve cells.
The UL researchers discovered that when they added extracts from red wine and green tea to human and animal brain cells and amyloid balls in the lab, the shape of the balls changed. This prevented the balls from attaching to the nerve cells and thus stopped the cells from dying.
This discovery doesn’t mean everyone should be downing bottles of red wine and green tea. However, it does open the door to more research and “the potential to reveal yet more drug targets,” noted Hooper.
Six more natural treatments for Alzheimer’s
Vitamin D and curcumin. Investigators from a 2012 study conducted at the University of California Los Angeles reported they had discovered mechanisms regulated by vitamin D3 that may promote the clearance of amyloid beta, which is the main ingredient of plaques associated with Alzheimer’s disease. In a previous study by the same research group, they had found some immune system cells in people with Alzheimer’s disease may respond to vitamin D3 and curcumin, a component of the spice turmeric.
In a separate, new study from China, investigators reported on the use of curcumin as a potential treatment for Alzheimer’s disease. In addition to amyloid, their research focused on astrocytes as major factors in early Alzheimer’s development. Star-shaped astrocytes are the most abundant cells in the brain.
The authors explained that in the lab, curcumin has been shown to inhibit amyloid accumulation and speed up the breakup of amyloid plaque, as well as increase expression of a marker important to astrocytes. In addition, curcumin improved the spatial memory (typical of Alzheimer’s) in rat models.
Omega-3 Fatty Acid DHA. A new (February 2013) small study has revealed that the omega-3 fatty acid docosahexaenoic acid (DHA) and vitamin D3 help improve removal of plaque and control inflammation, both critical features in the fight against Alzheimer’s disease.
The researchers found that DHA helps clear plaque in a way slightly different than does vitamin D3. Additional research may help reveal whether correcting deficiencies of DHA and vitamin D will help individuals eliminate amyloid plaque as a way to treat Alzheimer’s disease.
Coffee (caffeine). A study from the University of South Florida College of Pharmacy and the USF Health Byrd Alzheimer’s Institute reported that caffeinated coffee has a positive effect on older adults with mild memory impairment. According to lead author and neuroscientist Dr. Chuanhai Cao, their findings, “along with our earlier studies in Alzheimer’s mice, are very consistent in indicating that moderate daily caffeine/coffee intake throughout adulthood should appreciably protect against Alzheimer’s disease later in life.”
More specifically, the authors identified about three cups of coffee daily as the number necessary to enjoy this benefit. Co-author Dr. Gary W. Arendash, USF department of cell biology, microbiology and molecular biology, went so far as to state that “moderate daily consumption of caffeinated coffee appears to be the best dietary option for long-term protection against Alzheimer’s memory loss.”
Grape seed extract. A number of studies have shown that grape seed extract can interfere with the accumulation of toxic proteins characteristic of Alzheimer’s disease, as demonstrated by a mouse study from the Mount Sinai School of Medicine.
A more recent study from the University of Minnesota noted the impact of grape seed extract given to mouse models of Alzheimer’s disease. Five months of treatment significantly reduced brain levels of amyloid substances known to cause memory impairment. The authors noted they “strongly suggest” that grape seed extract “should be further tested as a potential prevention and/or therapy for AD.”
Vitamin E. The potent antioxidant vitamin E has been identified as having significant ability to help with the prevention and treatment of Alzheimer’s disease, although not all researchers agree. A recent meta-analysis in the Journal of Alzheimer’s Disease explored the results of seven studies that evaluated the use of vitamins C, E, and beta-carotene and the risk of Alzheimer’s disease.
The reviewers concluded that of the three antioxidants, vitamin E showed the most impressive protective effects against Alzheimer’s disease. However, all three did demonstrate an ability to lower the risk of the disease.
It’s true there are no effective treatments for Alzheimer’s disease in either the conventional or alternative/complementary areas of medicine. However, continuing exploration of potential natural treatments as well as medications may lead to effective answers.
SOURCES:
Cashman JR et al. Curcumins promote monocytic gene expression related to B-amyloid and superoxide dismutase clearance. Neurodegenerative Diseases 2012; 10(1-4): 274-76
Li FJ et al. Dietary intakes of vitamin E, vitamin C, and b-carotene and risk of Alzheimer’s disease: a meta-analysis.Journal of Alzheimer’s Disease 2012; 31(2): 253-58
Liu P et al. Grape seed polyphenolic extract specifically decreases aB*56 in the brains of Tg2576 mice. Journal of Alzheimer’s Disease 2011; 26(4): 657-66
Mizwicki MT et al. Genomic and nongenomic signaling induced by 1a,25(OH)2-vitamin D3 promotes the recovery of amyloid-B phagocytosis by Alzheimer’s disease macrophages. Journal of Alzheimer’s Disease 2012; 29(1): 51-62
Rushworth JV et al. Prion protein-mediated toxicity of amyloid-B oligomers requires lipid rafts and the transmembrane LRP1. Journal of Biological Chemistry 2013 Feb 5
Wang Y et al. Curcumin as a potential treatment for Alzheimer’s disease: a study of the effects of curcumin on hippocampal expression of glial fibrillary acidic protein. American Journal of Chinese Medicine 2013; 41(1): 59-70
Wang J et al. Grape derived polyphenols attenuate tau neuropathology in a mouse model of Alzheimer’s disease.Journal of Alzheimer’s Disease 2010; 22(2): 653-61

Thursday, February 14, 2013

New hope for dementia sufferers


Caregivers and healthcare professionals, here is some great information

Here is a great dementia resource for caregivers and healthcare professionals,


Your residents will love the Amazon Kindle Fire


Here is information on being the best caregiver you can be


Here is a way for nurses administrators, social workers and other health care  professionals to get an easyceu or two


Follow alzheimersideas on twitter

The Dementia Caregiver's Little Book of Hope [Kindle Edition

Medical Xpress

Researchers are investigating new ways to treat Alzheimer's disease by targeting the blood-brain barrier 

—Research that aims to rid dementia sufferers' brains of toxins could lead to a new treatment that reverses the symptoms of Alzheimer's disease in the future.

Researchers are investigating new ways to treat Alzheimer's by targeting the blood-brain barrier, which acts as a door to the brain, and is responsible for pumping toxins in the blood away from the brain. Dr Joseph Nicolazzo, from the Monash Institute of Pharmaceutical Sciences, in collaboration with the University of Washington, is examining pumps at the blood-brain barrier that are known to become dysfunctional in Alzheimer's patients. This diminished pumping action is believed to result in a build-up of the toxin amyloid in the brain, killing nerve cells and leading to memory loss associated with Alzheimer's. The researchers are investigating how to get the pumps working again, to safely filter toxins out of the brain. 

"Alzheimer's is the most common form of dementia affecting 300,000 Australians and 5.4 million Americans," Dr Nicolazzo said. "While there are medications that can assist with memory, there is currently no cure that can reverse the disease. "We hope that unravelling how to get the pumps working again to decrease amyloid build-up in the brain will lead to new drugs that may cure Alzheimer's disease."

Sunday, February 10, 2013

Ask a Doctor


Caregivers and healthcare professionals, here is some great information

Here is a great dementia resource for caregivers and healthcare professionals,


Your residents will love the Amazon Kindle Fire


Here is information on being the best caregiver you can be


Here is a way for nurses administrators, social workers and other health care  professionals to get an easyceu or two


Follow alzheimersideas on twitter

The Dementia Caregiver's Little Book of Hope [Kindle Edition

Now it is simple to ask a foctor about dementia or any other topic by tying in the question in the box on the righ. Then press "ask"
..
Your question will be answered by a top doctor in the field.

Your comments are welcome
Blog Flux Directory
alzheimersideas - whereIstand.com

Fitness is important in dementia prevention. Click below for more info